Nonalcoholic fatty liver disease (NAFLD), recently renamed metabolic-associated fatty liver
disease (MAFLD), is one of the most common causes of liver diseases worldwide. NAFLD is …

The liver is a dynamic organ that plays critical roles in many physiological processes,
including the regulation of systemic glucose and lipid metabolism. Dysfunctional hepatic …

Non-alcoholic fatty liver disease (NAFLD) is associated with a thorough reprogramming of
hepatic metabolism. Epigenetic mechanisms, in particular those associated with …

Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic pathology in
industrialized countries, affecting about 25% of the general population. NAFLD is a benign …

Recently non-alcoholic fatty liver disease (NAFLD) has grabbed considerable scientific
attention, owing to its rapid increase in prevalence worldwide and growing burden on end …

Background Non-alcoholic fatty liver disease (NAFLD) is a common hepatic disease with an
increasing prevalence but an unclear aetiology. This study aimed to investigate the …

Nonalcoholic fatty liver disease (NAFLD) impacts more than one‐third of the population and
is linked with other metabolic diseases. The term encompasses a wide spectrum of …

Background & Aims Serum microRNA (miRNA) levels are known to change in non-alcoholic
fatty liver disease (NAFLD) and may serve as useful biomarkers. This study aimed to profile …

Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease and
ranges from steatosis to steatohepatitis and to liver fibrosis. Lipotoxicity in hepatocytes …

Desmoplastic reaction is a fibrosis reaction that is characterized by a large amount of dense
extracellular matrix (ECM) and dense fibrous stroma. Fibrotic stroma around the tumor has …